Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural products as important tyrosine kinase inhibitors
Bo Yin, Dongmei Fang, Xian‐Li Zhou, et al.
European Journal of Medicinal Chemistry (2019) Vol. 182, pp. 111664-111664
Closed Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies
Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114491-114491
Open Access | Times Cited: 73
Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances
Prajwal Dhokne, Akash P. Sakla, Nagula Shankaraiah
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113334-113334
Closed Access | Times Cited: 86
Signaling Pathway and Small-Molecule Drug Discovery of FGFR: A Comprehensive Review
Jia Zheng, Wei Zhang, Linfeng Li, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 52
Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136021-136021
Closed Access | Times Cited: 37
Natural tyrosine kinase inhibitors acting on the epidermal growth factor receptor: Their relevance for cancer therapy
Yuan Liang, Tiehua Zhang, Jie Zhang
Pharmacological Research (2020) Vol. 161, pp. 105164-105164
Closed Access | Times Cited: 56
Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
Harpinder Kaur Brar, Jiney Jose, Zimei Wu, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 59-59
Open Access | Times Cited: 31
Targeting Autophagy with Natural Products as a Potential Therapeutic Approach for Cancer
Md. Abdul Alim Al‐Bari, Yuko Ito, Samrein B. M. Ahmed, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9807-9807
Open Access | Times Cited: 35
Recent advances in the development of EGFR degraders: PROTACs and LYTACs
Dawei Hong, Bizhong Zhou, Bei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 239, pp. 114533-114533
Closed Access | Times Cited: 26
Pegaharmols A–B, Axially Chiral β-Carboline-quinazoline Dimers from the Roots of Peganum harmala
Sheng-Ge Li, Yuetong Wang, Qin Zhang, et al.
Organic Letters (2020) Vol. 22, Iss. 19, pp. 7522-7525
Closed Access | Times Cited: 33
Qualitative Phytochemical Fingerprint and Network Pharmacology Investigation of Achyranthes aspera Linn. Extracts
Kouadio Ibrahime Sinan, Gökhan Zengin, Dimitrina Zheleva‐Dimitrova, et al.
Molecules (2020) Vol. 25, Iss. 8, pp. 1973-1973
Open Access | Times Cited: 31
Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs
Karolina Wojtowicz, Karolina Sterzyńska, Monika Świerczewska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4243-4243
Open Access | Times Cited: 26
Vitexin and Isovitexin Act through Inhibition of Insulin Receptor to Promote Longevity and Fitness in Caenorhabditis elegans
Mingfang Tao, Rong Li, Zhuo Zhang, et al.
Molecular Nutrition & Food Research (2022) Vol. 66, Iss. 17
Closed Access | Times Cited: 17
Natural Products in Precision Oncology: Plant-Based Small Molecule Inhibitors of Protein Kinases for Cancer Chemoprevention
Henry J. Thompson, Tymofiy Lutsiv
Nutrients (2023) Vol. 15, Iss. 5, pp. 1192-1192
Open Access | Times Cited: 10
Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations
Debojyoti Halder, Subham Das, R. S. Jeyaprakash
Molecular Diversity (2023)
Closed Access | Times Cited: 10
Dysregulated Pathways During Pregnancy Predict Drug Candidates in Neurodevelopmental Disorders
Huamin Yin, Zhendong Wang, Wenhang Wang, et al.
Neuroscience Bulletin (2025)
Closed Access
Dynamics understanding of novel solvated drug molecules against emerging Burkholderia Cepacia infections in immunocompromised patients
Sajjad Ahmad, Faisal Ahmad, Syed Ainul Abideen, et al.
Results in Chemistry (2025), pp. 102250-102250
Open Access
Identification and characterization of Bufalin as a novel EGFR degrader
Yidi Tai, Lulu Kong, Yan Wang, et al.
Cancer Letters (2025), pp. 217715-217715
Closed Access
Discovery and evaluation of cytisine N-isoflavones as novel EGFR/HER2 dual inhibitors
Yanqing Wang, Xiaoying Yin, Ling‐Yan Chen, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105868-105868
Closed Access | Times Cited: 15
Biological Evaluation of Selected Flavonoids as Inhibitors of MNKs Targeting Acute Myeloid Leukemia
Liang‐Chieh Chen, Han-Li Huang, Wei‐Chun HuangFu, et al.
Journal of Natural Products (2020) Vol. 83, Iss. 10, pp. 2967-2975
Closed Access | Times Cited: 23
Identification of anti-cancer compounds from natural products
Jin‐Jian Lu, Yitao Wang
Chinese Journal of Natural Medicines (2020) Vol. 18, Iss. 7, pp. 481-482
Closed Access | Times Cited: 22
Benzimidazole: A Multifacted Nucelus for Anticancer Agents
Yogita Bansal, Richa Minhas, Ankit Singhal, et al.
Current Organic Chemistry (2021) Vol. 25, Iss. 6, pp. 669-694
Closed Access | Times Cited: 20
Cannabidiol Effectively Promoted Cell Death in Bladder Cancer and the Improved Intravesical Adhesion Drugs Delivery Strategy Could Be Better Used for Treatment
Shanshan Chen, Changping Deng, Wenyun Zheng, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1415-1415
Open Access | Times Cited: 20
A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling
Ailin Yang, Qi Wu, Zhongdong Hu, et al.
Toxicology and Applied Pharmacology (2021) Vol. 431, pp. 115739-115739
Closed Access | Times Cited: 20
Advances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospects
Mohammad Fawad Ansari, Huzaifa Yasir Khan, Sartaj Tabassum, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108335-108335
Closed Access | Times Cited: 14
Design, semi-synthesis and examination of new gypsogenin derivatives against leukemia via Abl tyrosine kinase inhibition and apoptosis induction
Nafia Gökçe Ulusoy, Safiye Emirdağ, Ece Sözer, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 1487-1499
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top